Neximmune Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Neximmune last-minute Real Value cannot be determined due to lack of data. The latest price of Neximmune is $0.0. Our model forecasts the value of Neximmune from analyzing the firm fundamentals such as Shares Owned By Insiders of 17.00 %, current valuation of (491.95 K), and Return On Equity of -1.96 as well as examining its technical indicators and probability of bankruptcy.
Neximmune Total Value Analysis
Neximmune is now anticipated to have valuation of (491.95 K) with market capitalization of 3.25 M, debt of 68.81 K, and cash on hands of 53.13 M. The negative valuation of Neximmune may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Neximmune fundamentals.Takeover Price | Market Cap | Debt Obligations | Cash |
(491.95 K) | 3.25 M | 68.81 K | 53.13 M |
Neximmune Asset Utilization
One of the ways to look at asset utilization of Neximmune is to check how much profit was generated for every dollar of assets it reports. Neximmune secures a negative usage of assets of -0.7 %, losing $0.006971 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Neximmune shows how discouraging it operates for each dollar spent on its assets.Neximmune Ownership Allocation
Neximmune secures 17.0 % of its outstanding shares held by insiders and 11.17 % owned by institutional investors.Neximmune Profitability Analysis
Net Loss for the year was (32.34 M) with profit before overhead, payroll, taxes, and interest of 0.Neximmune Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 1 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Neximmune Pink Sheet
If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |